Metabolic Syndrome Predicts Refractoriness to Intravenous Thrombolysis in Acute Ischemic Stroke

Laura Dorado, Juan F. Arenillas, Elena López-Cancio, María Hernández-Pérez, Natalia Pérez De La Ossa, Meritxell Gomis, Mònica Millán, María Luisa Granada, Amparo Galán, Ernest Palomeras, Antoni Dávalos

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Abstract

© 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved. Background: Metabolic syndrome (MetS) has been associated with higher resistance to clot lysis at 24 hours after tissue plasminogen activator (tPA) administration in patients with acute ischemic stroke. We aimed to test this hypothesis at earlier time points, when neurointerventional rescue procedures may still be indicated to achieve arterial recanalization. Methods: This is a prospective and observational study in consecutive stroke patients with MCA occlusion treated with IV tPA. MetS was diagnosed following the unified criteria of the last Joint Interim Statement 2009 participating several major organizations. The primary outcome variable was resistance to thrombolysis, defined as the absence of complete middle cerebral artery recanalization 2 hours after tPA bolus assessed by transcranial color-coded duplex or when rescue mechanical thrombectomy after IV tPA was required. Secondary outcome variables were dramatic neurological improvement (decrease in ≥10 points, or a National Institutes of Health Stroke Scale [NIHSS] score of 0-1 at 24hours), symptomatic intracerebral hemorrhage following European-Australasian Acute Stroke Study II criteria, infarct volume at 24 hours (calculated by using the formula for irregular volumes, ABC/2), and good outcome (modified Rankin Scale score<3) at 3 months. Results: A total of 234 patients (median baseline NIHSS score 16 [10-20]) were included and 146 (62.4%) fulfilled MetS criteria. After multivariate analysis, MetS emerged as an independent predictor of resistance to thrombolysis (odds ratio=2.2 [1.3-4.2], P=.01) and absence of dramatic neurological improvement (odds ratio=.5 [.28-.97], P=.04). In addition, MetS conferred poorer functional outcome, higher symptomatic intracerebral hemorrhage rate, and increased infarct volume, although these associations disappeared after adjustment for covariates. Conclusions: MetS predicts patients with middle cerebral artery occlusion refractory to early clot dissolution after IV tPA. This finding may help in acute clinical decision-making.
Original languageEnglish
Pages (from-to)2605-2612
JournalJournal of Stroke and Cerebrovascular Diseases
Volume24
Issue number11
DOIs
Publication statusPublished - 1 Nov 2015

Keywords

  • Acute stroke
  • metabolic syndrome
  • outcome
  • thrombolysis

Fingerprint Dive into the research topics of 'Metabolic Syndrome Predicts Refractoriness to Intravenous Thrombolysis in Acute Ischemic Stroke'. Together they form a unique fingerprint.

Cite this